Cargando…

Zeb2 is a negative regulator of midbrain dopaminergic axon growth and target innervation

Neural connectivity requires neuronal differentiation, axon growth, and precise target innervation. Midbrain dopaminergic neurons project via the nigrostriatal pathway to the striatum to regulate voluntary movement. While the specification and differentiation of these neurons have been extensively s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hegarty, Shane V., Wyatt, Sean L., Howard, Laura, Stappers, Elke, Huylebroeck, Danny, Sullivan, Aideen M., O’Keeffe, Gerard W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561083/ https://www.ncbi.nlm.nih.gov/pubmed/28819210 http://dx.doi.org/10.1038/s41598-017-08900-3

Ejemplares similares

Targeting transcriptional regulators to regenerate midbrain dopaminergic axons in Parkinson's disease
por: Hegarty, Shane V., et al.
Publicado: (2017)

Targeting bone morphogenetic protein signalling in midbrain dopaminergic neurons as a therapeutic approach in Parkinson's disease
por: O'Keeffe, Gerard W., et al.
Publicado: (2017)

Inhibition of miR-181a promotes midbrain neuronal growth through a Smad1/5-dependent mechanism: implications for Parkinson’s disease
por: Hegarty, Shane V., et al.
Publicado: (2018)

Protocol for evaluation of neurotrophic strategies in Parkinson’s disease-related dopaminergic and sympathetic neurons in vitro
por: Hegarty, Shane V., et al.
Publicado: (2016)

Neurotrophic factors: from neurodevelopmental regulators to novel therapies for Parkinson's disease
por: Hegarty, Shane V., et al.
Publicado: (2014)

The Epigenome as a therapeutic target for Parkinson's disease
por: Hegarty, Shane V., et al.
Publicado: (2016)

TNF superfamily member APRIL enhances midbrain dopaminergic axon growth and contributes to the nigrostriatal projection in vivo
por: McWilliams, Thomas G., et al.
Publicado: (2017)

Gene Co-expression Analysis Identifies Histone Deacetylase 5 and 9 Expression in Midbrain Dopamine Neurons and as Regulators of Neurite Growth via Bone Morphogenetic Protein Signaling
por: Mazzocchi, Martina, et al.
Publicado: (2019)

Sonic Hedgehog Is a Chemoattractant for Midbrain Dopaminergic Axons
por: Hammond, Rachel, et al.
Publicado: (2009)

Association of distinct type 1 bone morphogenetic protein receptors with different molecular pathways and survival outcomes in neuroblastoma
por: Alshangiti, Amnah M., et al.
Publicado: (2020)

Editorial: The Role of Stem Cells, Epigenetics and MicroRNAs in Parkinson's Disease
por: Hegarty, Shane V., et al.
Publicado: (2020)

The dietary flavonoid isoliquiritigenin is a potent cytotoxin for human neuroblastoma cells
por: Alshangiti, Amnah M., et al.
Publicado: (2019)

Striatal vessels receive phosphorylated tyrosine hydroxylase-rich innervation from midbrain dopaminergic neurons
por: Afonso-Oramas, Domingo, et al.
Publicado: (2014)

Region-specific role of growth differentiation factor-5 in the establishment of sympathetic innervation
por: O’Keeffe, Gerard W., et al.
Publicado: (2016)

Wnt5a Regulates Midbrain Dopaminergic Axon Growth and Guidance
por: Blakely, Brette D., et al.
Publicado: (2011)

Ascending midbrain dopaminergic axons require descending GAD65 axon fascicles for normal pathfinding
por: García-Peña, Claudia M., et al.
Publicado: (2014)

Nolz1 expression is required in dopaminergic axon guidance and striatal innervation
por: Soleilhavoup, Clement, et al.
Publicado: (2020)

4-Hydroxychalcone Induces Cell Death via Oxidative Stress in MYCN-Amplified Human Neuroblastoma Cells
por: Alshangiti, Amnah M., et al.
Publicado: (2019)

A Zeb2-miR-200c loop controls midbrain dopaminergic neuron neurogenesis and migration
por: Yang, Shanzheng, et al.
Publicado: (2018)

Neurotrophic factor therapy for Parkinson's disease: past, present and future
por: Sullivan, Aideen M., et al.
Publicado: (2016)

Diet quality, sleep and quality of life in Parkinson’s disease: a cross-sectional study
por: Dunk, Danielle, et al.
Publicado: (2022)

miR-200 family controls late steps of postnatal forebrain neurogenesis via Zeb2 inhibition
por: Beclin, Christophe, et al.
Publicado: (2016)

Biophysical Properties of Somatic and Axonal Voltage-Gated Sodium Channels in Midbrain Dopaminergic Neurons
por: Yang, Jun, et al.
Publicado: (2019)

TWE-PRIL reverse signalling suppresses sympathetic axon growth and tissue innervation
por: Howard, Laura, et al.
Publicado: (2018)

Corrigendum: miR-200 family controls late steps of postnatal forebrain neurogenesis via Zeb2 inhibition
por: Beclin, Christophe, et al.
Publicado: (2016)

Pathological characteristics of axons and proteome patterns in midbrain dopaminergic neurodegeneration induced by WDR45-deficiency
por: Le, Weidong, et al.
Publicado: (2023)

Acquisition of the Midbrain Dopaminergic Neuronal Identity
por: Mesman, Simone, et al.
Publicado: (2020)

ZEB2, the Mowat-Wilson Syndrome Transcription Factor: Confirmations, Novel Functions, and Continuing Surprises
por: Birkhoff, Judith C., et al.
Publicado: (2021)

TNFα reverse signaling promotes sympathetic axon growth and target innervation
por: Kisiswa, Lilian, et al.
Publicado: (2013)

CD40L reverse signaling suppresses prevertebral sympathetic axon growth and tissue innervation
por: Calhan, Osman Yipkin, et al.
Publicado: (2020)

Rhythmic oscillations in the midbrain dopaminergic nuclei in mice
por: Oberto, Virginie J., et al.
Publicado: (2023)

STRAP and NME1 Mediate the Neurite Growth-Promoting Effects of the Neurotrophic Factor GDF5
por: Anantha, Jayanth, et al.
Publicado: (2020)

The class II histone deacetylases as therapeutic targets for Parkinson’s disease
por: Mazzocchi, Martina, et al.
Publicado: (2020)

Distribution of Midbrain Cholinergic Axons in the Thalamus
por: Huerta-Ocampo, Icnelia, et al.
Publicado: (2020)

Transplantation of novel human GDF5-expressing CHO cells is neuroprotective in models of Parkinson's disease
por: Costello, Daniel J, et al.
Publicado: (2012)

The potential of bone morphogenetic protein 2 as a neurotrophic factor for Parkinson's disease
por: Goulding, Susan R., et al.
Publicado: (2020)

Disrupted Functional Connectivity with Dopaminergic Midbrain in Cocaine Abusers
por: Tomasi, Dardo, et al.
Publicado: (2010)

Expression of endogenous Mkp1 in 6-OHDA rat models of Parkinson’s disease
por: Collins, Louise M, et al.
Publicado: (2014)

Zeb2 Regulates Myogenic Differentiation in Pluripotent Stem Cells
por: Di Filippo, Ester Sara, et al.
Publicado: (2020)

Diverse midbrain dopaminergic neuron subtypes and implications for complex clinical symptoms of Parkinson’s disease
por: Carmichael, Kathleen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gjmsu3vl03cf3cgt31gmtgnob7